These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 26716580

  • 1. Levetiracetam extended release for the treatment of patients with partial-onset seizures: A long-term, open-label follow-up study.
    Chung S, Ceja H, Gawłowicz J, McShea C, Schiemann J, Lu S.
    Epilepsy Res; 2016 Feb; 120():7-12. PubMed ID: 26716580
    [Abstract] [Full Text] [Related]

  • 2. Once-daily extended-release levetiracetam as adjunctive treatment of partial-onset seizures in patients with epilepsy: a double-blind, randomized, placebo-controlled trial.
    Peltola J, Coetzee C, Jiménez F, Litovchenko T, Ramaratnam S, Zaslavaskiy L, Lu ZS, Sykes DM, Levetiracetam XR N01235 Study Group.
    Epilepsia; 2009 Mar; 50(3):406-14. PubMed ID: 19317886
    [Abstract] [Full Text] [Related]

  • 3. Levetiracetam extended release conversion to monotherapy for the treatment of patients with partial-onset seizures: a double-blind, randomised, multicentre, historical control study.
    Chung S, Ceja H, Gawłowicz J, Avakyan G, McShea C, Schiemann J, Lu S.
    Epilepsy Res; 2012 Aug; 101(1-2):92-102. PubMed ID: 22516508
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Levetiracetam intravenous infusion as an alternative to oral dosing in patients with partial-onset seizures.
    Baulac M, Brodie MJ, Elger CE, Krakow K, Stockis A, Meyvisch P, Falter U.
    Epilepsia; 2007 Mar; 48(3):589-92. PubMed ID: 17326794
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of levetiracetam (up to 2000 mg/day) in Taiwanese patients with refractory partial seizures: a multicenter, randomized, double-blind, placebo-controlled study.
    Tsai JJ, Yen DJ, Hsih MS, Chen SS, Hiersemenzel R, Edrich P, Lai CW.
    Epilepsia; 2006 Jan; 47(1):72-81. PubMed ID: 16417534
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. An open-label study of levetiracetam at individualised doses between 1000 and 3000 mg day(-1) in adult patients with refractory epilepsy.
    Abou-Khalil B, Hemdal P, Privitera MD.
    Seizure; 2003 Apr; 12(3):141-9. PubMed ID: 12651078
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of ezogabine/retigabine as adjunctive therapy to specified single antiepileptic medications in an open-label study of adults with partial-onset seizures.
    Lerche H, Daniluk J, Lotay N, DeRossett S, Edwards S, Brandt C.
    Seizure; 2015 Aug; 30():93-100. PubMed ID: 26216692
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Safety and tolerability of lacosamide as adjunctive therapy for adults with partial-onset seizures: Analysis of data pooled from three randomized, double-blind, placebo-controlled clinical trials.
    Biton V, Gil-Nagel A, Isojarvi J, Doty P, Hebert D, Fountain NB.
    Epilepsy Behav; 2015 Nov; 52(Pt A):119-27. PubMed ID: 26414341
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Adjunctive levetiracetam in patients aged 1 month to <4 years with partial-onset seizures: subpopulation analysis of a prospective, open-label extension study of up to 48 weeks.
    Piña-Garza JE, Schiemann-Delgado J, Yang H, Duncan B, Hadac J, Hunter SJ.
    Clin Ther; 2010 Oct; 32(11):1935-50. PubMed ID: 21095488
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.